Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Millet

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Science Translational Medicine|January 18, 2019
An engineered <i>E. coli</i> Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humansCaroline B Kurtz, Yves A Millet, Marja K Puurunen, et al.
British Journal of Cancer|May 14, 2009
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonismB Cambien, B F Karimdjee, P Richard-Fiardo, et al.
Nature Biotechnology|August 14, 2018
Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuriaVincent M Isabella, Binh N Ha, Mary Joan Castillo, et al.
Therapeutic Advances in Medical Oncology|October 24, 2024
BLU-945, a potent and selective next-generation EGFR TKI, has antitumor activity in models of osimertinib-resistant non-small-cell lung cancerSun Min Lim, Stefanie S Schalm, Eun Ji Lee, et al.
Molecular Cancer Therapeutics|May 13, 2026
BLU-451, a CNS-Active, Potent, and Selective Small-Molecule Inhibitor Against Uncommon EGFR MutationsYves A Millet, Alexander I Spira, Christina S Baik, et al.
Scientific Reports|May 28, 2024
Bioarchaeology aids the cultural understanding of six characters in search of their agency (Tarquinia, ninth-seventh century BC, central Italy)G Bagnasco, M Marzullo, C Cattaneo, et al.
Translational Medicine @ Unisa|July 31, 2019
The Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy AgeingJ Bousquet, M Illario, J Farrell, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Science Translational Medicine|January 18, 2019
An engineered <i>E. coli</i> Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humansCaroline B Kurtz, Yves A Millet, Marja K Puurunen, et al.
British Journal of Cancer|May 14, 2009
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonismB Cambien, B F Karimdjee, P Richard-Fiardo, et al.
Nature Biotechnology|August 14, 2018
Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuriaVincent M Isabella, Binh N Ha, Mary Joan Castillo, et al.
Therapeutic Advances in Medical Oncology|October 24, 2024
BLU-945, a potent and selective next-generation EGFR TKI, has antitumor activity in models of osimertinib-resistant non-small-cell lung cancerSun Min Lim, Stefanie S Schalm, Eun Ji Lee, et al.
Molecular Cancer Therapeutics|May 13, 2026
BLU-451, a CNS-Active, Potent, and Selective Small-Molecule Inhibitor Against Uncommon EGFR MutationsYves A Millet, Alexander I Spira, Christina S Baik, et al.
Scientific Reports|May 28, 2024
Bioarchaeology aids the cultural understanding of six characters in search of their agency (Tarquinia, ninth-seventh century BC, central Italy)G Bagnasco, M Marzullo, C Cattaneo, et al.
Translational Medicine @ Unisa|July 31, 2019
The Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy AgeingJ Bousquet, M Illario, J Farrell, et al.
Pageof 7